IFNG and non-small cell lung carcinoma: In summary, our data demonstrate that in an ex vivo system consisting of dissociated and stimulated human NSCLC tumors, toripalimab elevated the expression of IFN-γ related gene signature, compared to pembrolizumab, consistent with our in vitro stimulated T cell experimental findings.